Copyright: ©Author(s) 2026.
World J Transl Med. Sep 28, 2026; 12(3): 122119
Published online Sep 28, 2026. doi: 10.5528/wjtm.122119
Published online Sep 28, 2026. doi: 10.5528/wjtm.122119
Figure 1 Schematic depiction of the crosstalk between cytokines and musculoskeletal disorders.
Created by Biorender.com. Central cytokine hub connects to panels showing synovitis, cartilage destruction, periodontal bone loss, and combined bone-muscle wasting. Arrows emphasize shared osteoimmunological pathways driving systemic bone fragility, musculoskeletal frailty, and chronic inflammatory disease across the lifespan. IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α; SASP: Senescence-associated secretory phenotype; OPG: Osteoprotegerin; RANKL: Receptor activator of nuclear factor (NF)-κB ligand; RANK: Receptor activator of NF-κB.
- Citation: Gunasekar A, Jeyaraman N, Chitra SB, Yudakar V, Bharadwaj S, Muthu S, Jeyaraman M. Interleukin-6 and tumor necrosis factor-α in osteoimmunology: Aging, and anticytokine therapies. World J Transl Med 2026; 12(3): 122119
- URL: https://www.wjgnet.com/2220-6132/full/v12/i3/122119.htm
- DOI: https://dx.doi.org/10.5528/wjtm.122119